Clinical Trial Update: Phase 1 Study of BAFF CAR-T Cells (LMY-920) for Non-Hodgkin Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating BAFF CAR-T cells (LMY-920) for non-Hodgkin lymphoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Non-hodgkin Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• BAFF CAR-T Cells (LMY-920)

Snippet

Sponsor: Luminary Therapeutics | Conditions: Lymphoma, Non-Hodgkin Lymphoma, B-Cell | Phase 1 | Status: RECRUITING